Angela MITSIAS, a/k/a Angel Mitsias, Plaintiff-Appellant,
v.
I-FLOW CORPORATION, Stryker Corporation, and Stryker Sales Corporation, Defendants-Appellees (Steven Levin, M.D., Defendant).
Appellate Court of Illinois, First District, Fifth Division.
*96 Bruce D. Goodman, Peter M. Dapier, Bradley D. Steinberg, Steinberg, Goodman & Kalish, Chicago, for Appellant.
Paul E. Wojcicki, Matthew C. Jardine, Segal McCambridge Singer & Mahoney, Ltd., Chicago, for I-Flow.
Anthony J. Anscombe, C. Kinnier Lastimosa, Sedgwick, Detert, Moran & Arnold LLP, Chicago, for Stryker Corporation and Stryker Sales Corporation.
OPINION
Justice JOSEPH GORDON delivered the judgment of the court, with opinion.
¶ 1 Plaintiff appeals the dismissal of her products liability suit against I-Flow Corporation, Stryker Corporation, and Stryker Sales Corporation (collectively, the product liability defendants) as time-barred under the two-year limitations period for product liability actions as set forth in section 13-213(d) of the Code of Civil Procedure (735 ILCS 5/13-213(d) (West 2008)).
¶ 2 Dr. Steven Levin performed surgery on plaintiff's left shoulder on October 24, 2001. Subsequently, plaintiff experienced severe pain in her shoulder and was diagnosed with glenohumeral chondrolysis, the destruction of cartilage in the shoulder joint. On October 22, 2003, plaintiff filed an initial medical malpractice suit against Dr. Levin. (Dr. Levin is not a party to the instant appeal.) During the course of discovery in that suit, plaintiff's expert Dr. Anthony Romeo was deposed in two phases, namely, on August 9, 2006, and on October 24, 2007. On August 9, 2006, he testified that the administration of a particular anesthetic agent via a continuous infusion device, also known as a "pain pump," had been showed to be "highly associated" with loss of articular cartilage. *97 On October 24, 2007, at the second phase of his deposition, Dr. Romeo testified that recently published medical literature suggested a link between pain pumps and plaintiff's condition.
¶ 3 Based upon this second deposition, on November 12, 2008, plaintiff voluntarily nonsuited her medical malpractice action. She then refiled her malpractice claims against Dr. Levin on February 11, 2009, adding two product liability counts sounding in strict liability and negligence against the pain pump manufacturers, which are the product liability defendants in the instant appeal.
¶ 4 The product liability defendants filed motions to dismiss plaintiff's product liability claims as untimely. The trial court granted their motions to dismiss. Plaintiff now appeals. For the reasons that follow, we reverse and remand.
¶ 5 I. BACKGROUND
¶ 6 The facts as alleged by plaintiff are as follows. Plaintiff injured her left shoulder while exercising on August 19, 2001. On October 24, 2001, Dr. Levin performed orthopedic surgery on her shoulder at Alexian Brothers Medical Center. As a part of the surgery, Dr. Levin installed a pain pump in plaintiff's left shoulder in order to release Marcaine, a local anesthetic, into the surrounding area during the postoperative recovery period. Following surgery, plaintiff allegedly experienced severe pain in her left shoulder and a significant reduction in its range of motion. As noted, she was eventually diagnosed with glenohumeral chondrolysis, the destruction of "articular cartilage," i.e., joint cartilage, in the shoulder.
¶ 7 On October 22, 2003, plaintiff filed her initial medical malpractice suit against Dr. Levin and Alexian Brothers Medical Center, alleging direct negligence on the part of Dr. Levin and direct negligence and respondeat superior liability on the part of Alexian Brothers Medical Center. Plaintiff did not assert any claims against the product liability defendants in that action.
¶ 8 On August 9, 2006, during the course of discovery, the parties deposed plaintiff's physician, Dr. Romeo. In response to questioning by counsel for Dr. Levin, Dr. Romeo listed three possible ways in which performance of the subject surgery could cause cartilage loss, including the following:
"A third possibility which has become more apparent recently is the use of an interarticular anesthetic agent, particularly a medicine called Marcaine, and so the use of a postoperative interarticular pain pump, which I'm not aware of whether that was done or not, has been shown over the last year-and-a-half to two years to be highly associated with a condition where articular cartilage is aggressively lost in the shoulder after arthroscopic stabilization."
Later in that same deposition, counsel for plaintiff asked Dr. Romeo about the use of Marcaine pain pumps as a potential cause of plaintiff's condition, and Dr. Romeo answered that "in the last year and a half there's been a growing body of evidence that this can cause cartilage death or necrosis and lead to the loss of cartilage in a shoulder."
¶ 9 On October 24, 2007, at the second phase of his deposition, Dr. Romeo testified to a link between the use of pain pumps and glenohumeral chondrolysis:
"Q. In 2007, is it recognized in the literature that the use of Marcaine pain pumps can, in fact, be a cause for loss or destruction of articular cartilage at the glenohumeral joint space?
A. Yes."
*98 Dr. Romeo further testified that the connection between pain pumps and glenohumeral chondrolysis "was not known" in 2001 when Dr. Levin performed surgery on plaintiff and was not discovered until "a few years later."
¶ 10 Plaintiff voluntarily dismissed her initial medical malpractice action on November 12, 2008. Subsequently, on February 11, 2009, plaintiff filed the instant suit, once more seeking damages against Dr. Levin on a medical malpractice theory and adding claims against the product liability defendants on theories of strict liability and negligence.
¶ 11 The product liability defendants filed motions to dismiss plaintiff's complaint as untimely pursuant to the two-year limitations period for product liability actions as stated in section 13-213(d) of the Code of Civil Procedure (735 ILCS 5/13-213(d) (West 2008)). The product liability defendants argued that, at the latest, the statutory limitations period for plaintiff's product liability claims began to run on the day that plaintiff filed her initial action in 2003, because upon the filing of such a claim Illinois law deemed her to be aware of an injury wrongfully caused. In response, plaintiff argued that the limitations period would not begin until October 24, 2007, the date of Dr. Romeo's second deposition session, at which she first became aware of the potential link between the use of a pain pump during her surgery and her injury.
¶ 12 In opposition to the product liability defendants' motion to dismiss, plaintiff filed an affidavit by Dr. Romeo in which he stated:
"It is my understanding, and opinion to a reasonable degree of medical certainty, that any information concerning potential chondrolysis caused by the wrongful use of pain pumps did not occur by publication for which a patient or other lay person might realize that chondrolysis might be wrongfully caused by pain pumps or their design or lack of warnings or instructions until the summer of 2007."
Dr. Romeo acknowledged that, in his deposition on August 9, 2006, he had mentioned that plaintiff's injuries could have been caused by the use of a pain pump to deliver an anesthetic. However, he stated:
"[M]y testimony only reflected the length of time and the amount of medication that was delivered by the pain pump, and was not intended nor did it reflect any information that any pain pump may be potentially unsafe or had lack of warnings. * * * At my deposition on August 9, 2006, I had no information, and when asked, imparted no information to Mr. Goodman [plaintiff's attorney], that the pain pumps were unsafe or unreasonably dangerous, or negligently designed or manufactured."
¶ 13 On January 14, 2010, the trial court granted the product liability defendants' motion to dismiss, explaining:
"I ruled on the pure legal issue as to whether or not once a plaintiff is put on inquiry notice that they were injured and that the injury was wrongfully caused, and I accept the premise that by filing a malpractice suit against the medical defendants, there's no doubt that there was that notice generated early and that some of the dates are a little cloudy in my head, but I think it was 2001 or 2002 that that trigger date as to the med mal defendants served as a trigger date for all purposes, defendants, all causes of action. So, that the statute of limitations as to the product liability case would start on that same date."
The trial court further acknowledged that, under this construction of the discovery *99 rule, "it could well be argued that prior to your ability to file in good faith a products liability case, that statute has already left."
¶ 14 The next day, on January 15, 2010, upon plaintiff's motion, the trial court granted plaintiff leave to file an amended complaint and struck the previously entered dismissals. In her amended complaint, plaintiff added the factual allegation that, prior to the summer of 2007, she could not have discovered that the pain pump used by Dr. Levin might have been the cause of her injury, because "[p]rior to the summer of 2007, information concerning potential chondrolysis caused by pain pumps did not exist. There was no information available that chondrolysis may be wrongfully caused by pain pumps or their design or lack of safe, suitable or proper warnings until the summer of 2007."
¶ 15 Following a hearing that day, the court again granted the product liability defendants' motions to dismiss the claims against them. The trial court also issued a finding under Illinois Supreme Court Rule 304(a) (eff.Feb.26, 2010) that there was no just reason to delay enforcement or appeal of its order. This appeal followed.
¶ 16 II. ANALYSIS
¶ 17 On appeal, plaintiff contends that the statute of limitations for her product liability claim should only begin to run when plaintiff knew or should have known that her injury was wrongfully caused by a product, rather than when she knew or should have known that her injury was wrongfully caused without regard to any specific source. She additionally contends that a contrary interpretation of the discovery rule would deny her rights under the due process and equal protection provisions of the United States and Illinois constitutions. The product liability defendants contest each of these contentions. They additionally argue that, in any event, plaintiff knew or should have known that her injury was wrongfully caused by a product no later than August 9, 2006, the date of Dr. Romeo's first deposition, during which he mentioned the use of a pain pump in connection with her injury. Thus, they claim that even under the interpretation of the discovery rule advocated by plaintiff, her February 11, 2009, suit was still untimely.
¶ 18 A.
¶ 19 The central issue in this case is how the discovery rule is applied when a plaintiff is aware that her injury might have been wrongfully caused by one source but is unaware that her injury might have been caused by another source and, in fact, could not be aware of that source because the causal link was as yet unknown to science. Defendants contend that as soon as an injured plaintiff becomes aware that her injury might have been wrongfully caused by any source, the plaintiff is under a duty to inquire as to all potential sources, and the statute of limitations therefore begins to run as to all causes of action, even causes of action that would not be discoverable at that time. Under such a rule, the statute of limitations on all claims resulting from plaintiff's injury would have started to run no later than October 22, 2003, the date upon which she filed her initial malpractice lawsuit against Dr. Levin, since she was certainly alerted to the possibility of some form of wrongful conduct at that point, even if she did not yet have any means of discovering that she had been injured by defendants' product. Plaintiff, on the other hand, contends that where a particular cause of action would not be discoverable through reasonable diligence, the statute of limitations as to that particular cause of action should be tolled until that cause of action becomes discoverable, even if the statute of limitations *100 has already started to run as to other causes of action arising out of the same injury. Thus, the statute would not begin to run on plaintiff's products liability claim until plaintiff knew or had reason to know that her injury could have been wrongfully caused by a product, which she asserts did not occur until Dr. Romeo's testimony regarding pain pumps at the second session of his deposition on October 24, 2007.
¶ 20 The statute of limitations for products liability actions, which governs the instant appeal, is set forth in section 13-213 of the Code of Civil Procedure and provides, in relevant part:
"(d) Notwithstanding the provisions of subsection (b) and paragraph (2) of subsection (c) if the injury complained of occurs within any of the periods provided by subsection (b) and paragraph (2) of subsection (c), the plaintiff may bring an action within 2 years after the date on which the claimant knew, or through the use of reasonable diligence should have known, of the existence of the personal injury, death or property damage, but in no event shall such action be brought more than 8 years after the date on which such personal injury, death or property damage occurred." (Emphasis added.) 735 ILCS 5/13-213(d) (West 2008).
¶ 21 In applying the two-year statute of limitations set forth in section 13-213(d) and similar statutes of limitations, Illinois courts have adopted a "discovery rule," which serves to "postpone the commencement of the relevant statute of limitations until the injured plaintiff knows or reasonably should have known that he has been injured and that his injury was wrongfully caused." Golla v. General Motors Corp.,
"This court has recently considered the discovery rule in depth in two cases, and has adopted a construction of the rule which can be termed neither narrow nor expansive. That is, we have held that the event which triggers the running of the statutory period is not the first knowledge the injured person has of his injury, and, at the other extreme, we have also held that it is not the acquisition of knowledge that one has a cause of action against another for an injury he has suffered. Rather, * * * the statute starts to run when a person knows or reasonably should know of his injury and also knows or reasonably should know that it was wrongfully caused." Knox,88 Ill.2d at 414-15 ,58 Ill.Dec. 725 ,430 N.E.2d at 980 .
Our supreme court has explained that this rule is intended to encourage diligent investigation on the part of potential plaintiffs without foreclosing claims of which plaintiffs could not have been aware, stating, "In that way, an injured person is not held to a standard of knowing the inherently unknowable [citation], yet once it reasonably appears that an injury was wrongfully caused, the party may not slumber on his rights." Nolan,
¶ 22 The notion of "wrongful cause," as it has been developed by courts in Illinois, has two elements: that of cause and that of wrongfulness. With regard to the first element, plaintiff must have sufficient information to conclude that her injury was caused by the acts of another. Nolan,
¶ 23 As for the element of wrongfulness, an injured plaintiff should reasonably know that her injury is wrongfully caused, and the statute of limitations begins to run, as soon as she has sufficient information about her injury and its cause to spark inquiry in a reasonable person as to whether the conduct of the party who caused her injury might be legally actionable. Knox,
¶ 24 Knowledge of "wrongful cause" does not require knowledge on the part of plaintiff that the defendant's conduct fits the technical legal definition of *102 negligence or that all the legal elements of a particular cause of action are otherwise satisfied. Knox,
"[S]uspecting wrongdoing clearly is not the same as knowing that a wrong was probably committed. * * * The trier of fact must examine the factual circumstances upon which the suspicions are predicated and determine if they would lead a reasonable person to believe that wrongful conduct was involved. The fact that a party suspects wrongful conduct, without examining the reasons underlying those suspicions, is not enough to constitute constructive knowledge that an injury was wrongfully caused." Young v. McKiegue,303 Ill.App.3d 380 , 390,236 Ill.Dec. 907 ,708 N.E.2d 493 , 501 (1999).
See LaManna v. G.D. Searle & Co.,
¶ 25 Our supreme court has not directly addressed the operation of the statute of limitations where a plaintiff is aware that her injury might have been wrongfully caused by one source, but could not as yet have been aware of another potential source at that time. However, in defining the contours of the discovery rule in Nolan and Knox, our supreme court looks for guidance to the United States Supreme Court decision of United States v. Kubrick,
¶ 26 The Kubrick plaintiff brought suit in 1972 to recover for a hearing loss allegedly caused by medical malpractice in a Veterans Administration hospital. Kubrick,
"We are unconvinced that for statute of limitations purposes a plaintiff's ignorance *103 of his legal rights and his ignorance of the fact of his injury or its cause should receive identical treatment. That he has been injured in fact may be unknown or unknowable until the injury manifests itself; and the facts about causation may be in the control of the putative defendant, unavailable to the plaintiff or at least very difficult to obtain. The prospect is not so bleak for a plaintiff in possession of the critical facts that he has been hurt and who has inflicted the injury. He is no longer at the mercy of the latter. There are others who can tell him if he has been wronged, and he need only ask. If he does ask and if the defendant has failed to live up to minimum standards of medical proficiency, the odds are that a competent doctor will so inform the plaintiff." (Emphasis added.) Kubrick,444 U.S. at 122 ,100 S.Ct. 352 .
With regard to the facts of the case at hand, the Kubrick Court stated that, given the trial court's factual finding that the treatment at issue violated the standard of care, which was not contested on appeal, plaintiff "need only have made inquiry among doctors with average training and experience in such matters to have discovered that he probably had a good cause of action." Kubrick,
¶ 27 Thus, the fact that plaintiff could have discovered his cause of action within the statutory period through reasonable diligence forms a central part of the Kubrick Court's analysis. As noted, the need for plaintiffs to investigate their potential claims with reasonable diligence has likewise shaped the development of the discovery rule in Illinois. See Knox,
¶ 28 The present case, as noted, requires us to rule upon the operation of the discovery rule in a situation where a plaintiff is aware of one potential wrongful cause of her injury, but she does not yet know, nor could she reasonably discover, a second potential wrongful cause, because the state of our scientific knowledge is as yet inadequate to unearth that second cause. Permitting knowledge of the one to trigger the discovery rule as to the other would seem to defeat the policy and purpose behind the discovery rule, which is to accommodate the need of the victim, upon reasonable inquiry, to discover her cause of action against a defendant who has wronged her. Therefore, where plaintiff has discovered one cause of her injury, but has not and, in fact, could not have discovered a second cause, tolling the statute of limitations with regard to that second claim until such time as "[t]here are others *104 who can tell him if he has been wronged, and he need only ask" (Kubrick,
¶ 29 In the instant case, accepting the allegations in plaintiff's amended complaint as true, plaintiff did not slumber on her rights. She brought a timely medical malpractice suit within two years of her injury, and her delay in bringing her products liability suit was not due to any lack of diligence on her part but, rather, to the fact that the scientific community was not aware of the dangers associated with pain pumps until the summer of 2007. Indeed, while there may be a question of fact as to when the link between pain pumps and chondrolysis became known to science, there is no question that plaintiff could not have known of any potential products liability cause of action against the pain pump manufacturers while the causal link between her injury and the pain pump used upon her was not scientifically discoverable. As has been discussed, our supreme court has expressed concern that plaintiffs should not be "held to a standard of knowing the inherently unknowable." Nolan,
¶ 30 Plaintiff additionally contends, and we agree, that the rule she urges comports with the statutory scheme enacted by the legislature with regard to products liability claims, as reflected in section 13-213 of the Code of Civil Procedure:
"(b) Subject to the provisions of subsections (c) and (d) no product liability action based on any theory or doctrine shall be commenced except within the applicable limitations period and, in any event, within 12 years from the date of first sale, lease or delivery of possession by a seller or 10 years from the date of first sale, lease or delivery of possession to its initial user, consumer, or other non-seller, whichever period expires earlier, of any product unit that is claimed to have injured or damaged the plaintiff * * *.
* * *
(d) Notwithstanding the provisions of subsection (b) and paragraph (2) of subsection (c) if the injury complained of occurs within any of the periods provided by subsection (b) and paragraph (2) of subsection (c), the plaintiff may bring an action within 2 years after the date on which the claimant knew, or through the use of reasonable diligence should have known, of the existence of the personal injury, death or property damage, but in no event shall such action be brought more than 8 years after the date on which such personal injury, death or property damage occurred." 735 ILCS 5/13-213 (West 2008).
Thus, the products liability statute makes a clear distinction between the statute of repose, which is either 10 years or 12 years depending on the product's sales history, and the statute of limitations for products liability actions, which is 2 years from the date that the plaintiff discovers her injury. 735 ILCS 5/13-213 (West *105 2008). The statute further limits liability by stating that product liability actions based on injury, regardless of the time of discovery, must be brought within eight years of the injury, thus creating a rigid span of time after which recovery is impossible regardless of whether plaintiff's failure to discover her claim was due to any lack of diligence on her part. 735 ILCS 5/13-213(d) (West 2008). The interpretation of the discovery rule urged by defendants in this appeal would disrupt this statutory scheme in cases such as the present one by, in effect, transforming the two-year statute of limitations into a new statute of repose, since it would serve as an absolute bar on liability on claims that are not discoverable within that two-year period, as long as plaintiff has been alerted to the potential presence of at least one other claim.
¶ 31 Thus, in keeping with the statute itself, the thrust of Kubrick as cited with approval by our supreme court in Nolan and Knox, and our supreme court's concern that plaintiffs should investigate their claims with diligence without being "held to a standard of knowing the inherently unknowable" (Nolan,
¶ 32 Defendants argue that our holding is contrary to the language of Knox, citing Knox for the proposition that "the statute [of limitations] is not triggered with `the acquisition of knowledge that one has a cause of action against another for an injury he has suffered.'" (Emphasis in original.) See Knox,
¶ 33 Defendants nevertheless cite Hoffman v. Orthopedic Systems, Inc.,
¶ 34 Hoffman, like the present case, involves a plaintiff injured in surgery who was aware of a potential malpractice claim but did not discover that she might have a products liability claim until years later. Four to six months after being severely injured as a result of back surgery, the Hoffman plaintiff asked her attorney to investigate any potential medical malpractice claim arising out of that surgery, though it would appear that she did not conduct any investigation into potential products liability claims or file any suit at that time. Hoffman,
¶ 35 Under these facts, the Hoffman court found that plaintiff's claim was time-barred by the two-year statute of limitations for product liability actions, holding that it began to run no later than four to six months after her injury, when she requested that her attorney investigate a possible malpractice claim. Hoffman,
"Plaintiff's failure to pursue a more thorough inquiry to find the cause of her injuries does not excuse her from failing to comply with the statute of limitations. Plaintiff could have attempted to obtain the results of the hospital's investigation of this incident, with appropriate further investigation by her attorneys, particularly since Dr. Conrad voluntarily divulged its conclusions.
* * * It would be manifestly unjust to visit a stale claim upon a putative defendant by reason of inadequate investigative procedures, particularly where the Code and supreme court rules provide substantial avenues of inquiry to a plaintiff who knew that the potential for wrongdoing could have been the cause of her injuries." Hoffman, 327 Ill.App.3d *107 at 1011,262 Ill.Dec. 290 ,765 N.E.2d at 122 .
Thus, the Hoffman decision appears to rely, at least in part, on its determination that plaintiff's product liability claim would have been discoverable through diligent investigation, a reliance which comports with our supreme court's concern that putative plaintiffs investigate potential claims instead of slumbering on their rights. See Nolan,
¶ 36 Similarly, in McCormick and Wells, the court also relies in part upon plaintiffs' failure to investigate fully upon learning of their injuries in finding the claims at issue to be time-barred. Both of these cases are medical malpractice suits in which an injured plaintiff originally sought recovery against a certain doctor or doctors but did not discover facts implicating the defendant doctor until years later. In McCormick, the defendant physician treated plaintiff's kidney obstruction in 1984, and plaintiff's kidney subsequently became nonfunctional. McCormick,
¶ 37 In reaching this conclusion, the McCormick court stated that a plaintiff's cause of action does not accrue when plaintiff becomes aware that his injury may have been caused by the wrongful actions of a particular defendant but, rather, as soon as he becomes aware that his injury may have been caused by wrongful conduct in general. McCormick,
¶ 38 Finally, in Wells,
¶ 39 In this regard, we find the California case of Fox v. Ethicon Endo-Surgery, Inc.,
"We conclude that, under the delayed discovery rule, a cause of action accrues and the statute of limitations begins to run when the plaintiff has reason to suspect an injury and some wrongful cause, unless the plaintiff pleads and proves that a reasonable investigation at that time would not have revealed a factual basis for that particular cause of action. In that case, the statute of limitations for that cause of action will be tolled until such time as a reasonable investigation would have revealed its factual basis." Fox,27 Cal.Rptr.3d 661 ,110 P.3d at 917 .
¶ 40 The facts of Fox are analogous to those in the instant case. The plaintiff in Fox was injured as a result of gastric bypass surgery and brought a medical malpractice suit against the doctor who performed the surgery on April 6, 2000. Fox,
¶ 41 In assessing these facts, the California Supreme Court applied its discovery rule, which "postpones accrual of a cause of action until the plaintiff discovers, or has cause to discover, the cause of action." Fox,
¶ 42 In rendering this holding, the Fox court explicitly rejected the proposition that "`[w]hen a plaintiff has cause to sue based on knowledge or suspicion of negligence the statute starts to run as to all potential defendants.'" (Emphasis in original.) Fox,
"Were plaintiffs required to file all causes of action when one cause of action accrued, * * * they would run the risk of sanctions for filing a cause of action without any factual support. [Citations.] Indeed, it would be difficult to describe a cause of action filed by a plaintiff, before that plaintiff reasonably suspects that the cause of action is a meritorious one, as anything but frivolous." Fox,27 Cal.Rptr.3d 661 ,110 P.3d at 925 .
The Fox court further emphasized that such a rule would not encourage plaintiffs to employ dilatory tactics or "wait for the facts." Fox,
¶ 43 We find the rule and the reasoning of Fox to be in line with the discovery rule as it has developed in Illinois, for the reasons stated above. In particular, as noted, Illinois has an interest in encouraging reasonable diligence by plaintiffs in investigating potential tort claims (Knox,
¶ 44 Due to our resolution of this issue, we need not reach plaintiff's contention that interpretation of the discovery rule to bar her product liability claims would be a violation of her procedural due process rights and her right to equal protection of the laws.
¶ 45 B.
¶ 46 Defendants finally contend that, notwithstanding the foregoing, the trial court was correct in dismissing plaintiff's product liability claims as time-barred because plaintiff should have known that her injury might have been caused by defendants' product no later than August 9, 2006, the date of Dr. Romeo's first deposition, when he mentioned that postoperative delivery of the anesthetic Marcaine via a pain pump might have been a contributing cause to plaintiff's injury.
¶ 47 At the outset, plaintiff argues that we do not have jurisdiction to consider this question, since, in granting defendants' motion to dismiss, the trial court accepted defendants' construction of the discovery rule and explicitly rejected the need to reach this issue. However, we disagree with plaintiff's contention, as we may affirm on any basis appearing in the record, whether or not the trial court relied on that basis. See, e.g., Busch v. Graphic Color Corp.,
¶ 48 Plaintiff nevertheless cites Goodrich v. Sprague,
¶ 49 Goodrich is inapplicable to the instant case because, unlike in Goodrich, we are not ruling upon a motion which the trial court declined to consider. Rather, we are considering the merits of defendants' motion to dismiss, a motion which the trial court granted. Defendants are merely attempting to proffer alternative grounds for granting a motion upon which the trial court has already ruled and from which the instant appeal was taken. This motion would therefore be a "matter[ ] in controversy which [has] been ruled upon by the trial court" within the meaning of Goodrich. The case of Canel & Hale, Ltd. v. Tobin,
¶ 50 Plaintiff's attempted reliance on Marshall v. Burger King Corp.,
¶ 51 Nor can support for plaintiff's jurisdictional argument be found in the final case cited by plaintiff on this matter, Graves v. Illinois Liquor Control Comm'n,
¶ 52 Plaintiff next contends substantively that the question of when she knew or should have known that her injury might have been wrongfully caused by a pain pump is a disputed question of fact and therefore cannot be resolved upon a motion to dismiss. We agree. The question of when a party knew or reasonably should have known that she was injured and that her injury was wrongfully caused is a question of fact unless the facts are undisputed and only a single conclusion may be drawn from them. Nolan, 85 *112 Ill.2d at 171,
¶ 53 With regard to Dr. Romeo's 2006 deposition testimony, upon which defendants attempt to rely, plaintiff argues that such testimony does not unambiguously point to a causal link between plaintiff's injury and the use of a pain pump. Rather, she argues, it points to a causal link between plaintiff's injury and the use of the anesthetic Marcaine, which incidentally would have been administered via a pain pump:
"A third possibility which has become more apparent recently is the use of an interarticular anesthetic agent, particularly a medicine called Marcaine, and so the use of a postoperative interarticular pain pump, which I'm not aware of whether that was done or not, has been shown over the last year-and-a-half to two years to be highly associated with a condition where articular cartilage is aggressively lost in the shoulder after arthroscopic stabilization."
Plaintiff further argues that this interpretation is supported by Dr. Romeo's November 23, 2009, affidavit, submitted by plaintiff to the court in opposition to defendants' motion to dismiss, in which Dr. Romeo specifically disclaims having had any knowledge in 2006 that pain pumps themselves were potentially unsafe:
"[M]y [2006] testimony only reflected the length of time and the amount of medication that was delivered by the pain pump, and was not intended nor did it reflect any information that any pain pump may be potentially unsafe or had lack of warnings. * * * At my deposition on August 9, 2006, I had no information, and when asked, imparted no information to Mr. Goodman [plaintiff's attorney], that the pain pumps were unsafe or unreasonably dangerous, or negligently designed or manufactured."
In that affidavit, Dr. Romeo additionally denies any possibility that plaintiff could have discovered the connection between her injury and the pain pump prior to the summer of 2007:
"It is my understanding, and opinion to a reasonable degree of medical certainty, that any information concerning potential chondrolysis caused by the wrongful use of pain pumps did not occur by publication for which a patient or other lay person might realize that chondrolysis might be wrongfully caused by pain pumps or their design or lack of warnings or instructions until the summer of 2007."
This is consistent with plaintiff's allegation in her amended complaint that she could not have discovered her potential products liability claim before the summer of 2007 because "[p]rior to the summer of 2007, information concerning potential chondrolysis caused by pain pumps did not exist."
¶ 54 Based upon the averments of Dr. Romeo in his affidavit, as well as the facial ambiguity of Dr. Romeo's 2006 testimony as to the nature of the link between Marcaine, pain pumps, and chondrolysis, we find that it would not be unreasonable for a finder of fact to conclude that a reasonable person in plaintiff's position could not have been aware that her injury might have been wrongfully caused by a pain pump until the summer of 2007, due to the alleged lack of published information on the causal link between pain pumps and chondrolysis prior to that time. Accordingly, in ruling upon defendants' motion to dismiss, it would be inappropriate for us to resolve the disputed issue of fact as to whether plaintiff could have discovered her claim through reasonable diligence prior to the summer of 2007. See Nolan, 85 Ill.2d *113 at 171,
¶ 55 We note parenthetically that defendants have not attempted to preclude the use of Dr. Romeo's subsequent affidavit to explain or modify his testimony in his 2006 deposition. Nor is it conclusive that any such argument would be likely to succeed in any event, although there is authority to indicate that, where an expert witness of a party makes a clear, deliberate, and unequivocal statement of fact, such statement may be treated as the equivalent of a judicial admission so as to preclude subsequent contradiction by the deponent. See Schmall v. Village of Addison,
¶ 56 As urged by the plaintiff, it is at best unclear whether Dr. Romeo's 2006 testimony is referring to knowledge that would find fault with the use of the drug Marcaine or whether he is indicating a deficiency in the pain pump resulting from any inadequacy or defect. Thus, subsequent clarification would be permitted. However, in any event, even if the expert's testimony were sufficiently clear and deliberate, any potential argument as to whether his subsequent affidavit could contradict his earlier deposition testimony would be subject to forfeiture since defendants failed to raise this issue at any time. See Ill. S.Ct. R. 341(h)(7), (i) (eff. July 1, 2008); Elementary School District 159 v. Schiller,
¶ 57 Therefore, for the foregoing reasons, the judgment of the trial court is reversed and remanded for proceedings not inconsistent with this opinion.
¶ 58 Reversed and remanded.
Presiding Justice EPSTEIN and Justice McBRIDE concurred in the judgment and opinion.
